0001921094-25-000309.txt : 20250312 0001921094-25-000309.hdr.sgml : 20250312 20250312164740 ACCESSION NUMBER: 0001921094-25-000309 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250312 DATE AS OF CHANGE: 20250312 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals International, plc CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 25732369 BUSINESS ADDRESS: STREET 1: 23 OLD BOND STREET, FLOOR 3 CITY: LONDON STATE: X0 ZIP: WIS 4PZ BUSINESS PHONE: 7814319100 MAIL ADDRESS: STREET 1: 23 OLD BOND STREET, FLOOR 3 CITY: LONDON STATE: X0 ZIP: WIS 4PZ FORMER COMPANY: FORMER CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. DATE OF NAME CHANGE: 20180205 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Megna Michael R CENTRAL INDEX KEY: 0001464583 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 1050 HINGHAM STREET CITY: ROCKLAND STATE: MA ZIP: 02370 144 1 primary_doc.xml 144 0001464583 XXXXXXXX LIVE 0001730430 Kiniksa Pharmaceuticals International, plc 001-38492 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100 Megna Michael R Officer Common Charles Schwab & Co., Inc.

3000 Schwab Way Westlake TX 76262

9051 203207.00 42009500 03/12/2025 NASDAQ Common 03/12/2025 Employee Stock Option Exercise Kiniksa Pharmaceuticals, Ltd. N 9051 03/12/2025 Broker Payment for Cashless Exercise Y 03/12/2025 07/24/2024 Michael R Megna